CINGAL 4ml injection could be a one of a kind combination of cross-linked hyaluronic corrosive and triamcinolone hexacetonide planned to securely and successfully treat the torment and certain symptoms associated with osteoarthritis. Hyaluronic corrosive (HA) may be a natural substance delivered by the body.
The chemical is ordinarily found in tall sums within the joint tissue and within the liquid that encompasses the joints. In cases of osteoarthritis, the amount of common HA is decreased and the quality may be poorer than ordinary, which causes bothering and irritation, torment and solidness within the joints. CINGAL® includes HA to the joints where it acts as a oil and stun safeguard, whereas the triamcinolone hexacetonide decreases the aggravation. CINGAL® as it were requires a single infusion to attain quick acting and long enduring torment relief.
The pack consists of:
- 1 Syringe x 4ml per pack
The composition of CINGAL®:
- 88 mg Hyaluronic acid
- 18 mg Triamcinolone hexacetonide
Benefits of CINGAL®:
- Immediate pain relief and better joint mobility
- Long lasting results
- Areas: Approved for all synovial joints
How long does the result last for?
In general, CINGAL® can relieve knee pain up to 6 months. Some patients experience pain relief for longer than 6 months.
WHAT IS CINGAL INJECTION USED FOR?
Cingal is used for alleviating pain associated with OA by reducing the inflammation that is also associated with the disease. It can be safely injected into all synovial joints (e.g. knees, hips, shoulders, thumbs, etc.). Patients who are not able to improve their OA condition by exercise, physical therapy, and oral analgesics are indicated to receive Cingal injections. Just one injection is adequate to provide pain relief.
HOW DOES IT WORK?
Osteoarthritis (OA) is a degenerative disease of a synovial joint and is triggered by numerous factors, such as previous joint injuries, overuse of a joint, and being overweight or obese. Under normal circumstances, a healthy synovial joint is composed of a flexible synovial membrane in which the ends of the bones are contained. The ends of bones are also covered with a thin layer of tough articular cartilage that allows the joint to be highly mobile with very minimal friction. Besides that, the intra-articular space between the bones is also filled with synovial fluid that protects the joint by lubricating it and absorbing sudden impacts. Unfortunately, the aforementioned factors can affect the integrity of articular cartilage, resulting in the debilitating symptoms of OA, which can include pain, swelling, joint stiffness, and reduced mobility. If left untreated, OA and its symptoms reduce one’s quality of life drastically.
Cingal is designed with a combination of high molecular weight, cross-linked hyaluronic acid gel that contains micronized triamcinolone hexacetonide particles. The hyaluronic acid mimics the action of synovial fluid and helps to lubricate the affected synovial joint. The other active ingredient — micronized triamcinolone hexacetonide — is a type of rapid and long-lasting synthetic glucocorticosteroid with excellent immunosuppressive and anti-inflammatory activities that help to alleviate inflammatory symptoms of OA. Following an intra-articular injection of Cingal, the pain of OA is successfully suppressed
THE ORIGIN OF THIS PRODUCT IS FROM THE EUROPEAN COMMUNITY (EC)